ConductScience.org, home

Paper3854

Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.

Creese I and 2 others. Science, 1976. Cited by 1,843 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Papers, record 3854. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3854

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.
PubMed
Journal
Science
PubMed
Year
1976
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
1,843
iCite
Relative citation ratio, by iCite
53.7
iCite
Revised in PubMed
2019-06-18
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Creese II
2Burt DRD R
3Snyder SHS H

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antipsychotic AgentsMajor topic
ButyrophenonesMajor topic
DopamineMajor topic
Receptors, DrugMajor topic
SchizophreniaMajor topic
Adenylyl Cyclases
Animals
Binding, Competitive
Corpus Striatum
Dopamine Antagonists
Haloperidol
Humans
Olfactory Bulb
Phenothiazines
Structure-Activity Relationship

Source PubMed

Cited by461

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,843 citations.

PMIDTitleJournalYearIn PapersSource
42,931,251Two Coordinates for Dopamine in the Basal Ganglia.NeuroSci2026https://conductscience.org/library/papers/42931251PubMed
42,927,497Volatilomics in psychiatric biomarker research: from odor signatures to multiomic integration.Eur Arch Psychiatry Clin Neurosci2026https://conductscience.org/library/papers/42927497PubMed
42,803,324Lost in translation: why don't dopamine D2 antagonists cure addictions?J Psychiatry Neurosci2026https://conductscience.org/library/papers/42803324PubMed
42,446,851Animal Models for Drug Discovery in Schizophrenia: A Critical View from a Clinical Perspective.Pharmaceut Med2026https://conductscience.org/library/papers/42446851PubMed
42,016,325SARS-CoV-2 Spike Protein S1 Subunit Induces Neuroinflammation Via Microglial Kv1.3 Channel.Biol Psychiatry Glob Open Sci2026https://conductscience.org/library/papers/42016325PubMed
41,750,209Association Between Caffeine Levels and Symptom Profile in Schizophrenia: Results from a Cohort Study in Central Greece.Brain Sci2026https://conductscience.org/library/papers/41750209PubMed
41,664,080The gene expression landscape of disease genes.Genome Biol2026https://conductscience.org/library/papers/41664080PubMed
41,171,924Dorsomedial striatum monitors unreliability of current action policy and probes alternative one via the indirect pathway.Sci Adv2025https://conductscience.org/library/papers/41171924PubMed
41,132,847Discovery and proof-of-concept study of a novel highly selective sigma-1 receptor agonist for antipsychotic drug development.Acta Pharm Sin B2025https://conductscience.org/library/papers/41132847PubMed
41,102,143The neural basis for uncertainty processing in hierarchical decision making.Nat Commun2025https://conductscience.org/library/papers/41102143PubMed
41,052,274Antipsychotic drugs at 75: the past, present, and future of psychosis management.Br Med Bull2025https://conductscience.org/library/papers/41052274PubMed
41,031,373Toward biomimetic optogenetics: Drug-free activation of acute opiate reward.iScience2025https://conductscience.org/library/papers/41031373PubMed
40,983,366D1/D5 receptor activation promotes long-term potentiation and synaptic tagging/capture in hippocampal area CA2.FEBS J2026https://conductscience.org/library/papers/40983366PubMed
40,970,410HMG-CoA reductase inhibitors (statins) versus placebo for people with schizophrenia.Cochrane Database Syst Rev2025https://conductscience.org/library/papers/40970410PubMed
40,806,385Serotonin Modulation of Dorsoventral Hippocampus in Physiology and Schizophrenia.Int J Mol Sci2025https://conductscience.org/library/papers/40806385PubMed
40,655,977Common changes in rat cortical gene expression after chronic treatment with chlorpromazine and haloperidol may be related to their antipsychotic efficacy.Neurosci Appl2023https://conductscience.org/library/papers/40655977PubMed
40,405,017An ace in the hole? Opportunities and limits of using mice to understand schizophrenia neurobiology.Mol Psychiatry2025https://conductscience.org/library/papers/40405017PubMed
40,340,862Chlorpromazine directly inhibits Kv1.3 channels by facilitating the inactivation of channels.Mol Brain2025https://conductscience.org/library/papers/40340862PubMed
40,269,187LRRK2 mediates haloperidol-induced changes in indirect pathway striatal projection neurons.Mol Psychiatry2025https://conductscience.org/library/papers/40269187PubMed
40,141,736Third-Generation Antipsychotics: The Quest for the Key to Neurotrophism.Life (Basel)2025https://conductscience.org/library/papers/40141736PubMed

See all 461 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3854

GET https://conductscience.org/api/papers/v1/3854/cited_by?page=2